Howard R L, Avery A J, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M
Nottingham Primary Care Research Partnership, Broxtowe & Hucknall PCT, Hucknall Health Centre, Nottingham, UK.
Br J Clin Pharmacol. 2007 Feb;63(2):136-47. doi: 10.1111/j.1365-2125.2006.02698.x. Epub 2006 Jun 26.
Previous systematic reviews have found that drug-related morbidity accounts for 4.3% of preventable hospital admissions. None, however, has identified the drugs most commonly responsible for preventable hospital admissions. The aims of this study were to estimate the percentage of preventable drug-related hospital admissions, the most common drug causes of preventable hospital admissions and the most common underlying causes of preventable drug-related admissions.
Bibliographic databases and reference lists from eligible articles and study authors were the sources for data. Seventeen prospective observational studies reporting the proportion of preventable drug-related hospital admissions, causative drugs and/or the underlying causes of hospital admissions were selected. Included studies used multiple reviewers and/or explicit criteria to assess causality and preventability of hospital admissions. Two investigators abstracted data from all included studies using a purpose-made data extraction form.
From 13 papers the median percentage of preventable drug-related admissions to hospital was 3.7% (range 1.4-15.4). From nine papers the majority (51%) of preventable drug-related admissions involved either antiplatelets (16%), diuretics (16%), nonsteroidal anti-inflammatory drugs (11%) or anticoagulants (8%). From five studies the median proportion of preventable drug-related admissions associated with prescribing problems was 30.6% (range 11.1-41.8), with adherence problems 33.3% (range 20.9-41.7) and with monitoring problems 22.2% (range 0-31.3).
Four groups of drugs account for more than 50% of the drug groups associated with preventable drug-related hospital admissions. Concentrating interventions on these drug groups could reduce appreciably the number of preventable drug-related admissions to hospital from primary care.
以往的系统评价发现,药物相关的发病率占可预防住院病例的4.3%。然而,尚无研究确定导致可预防住院病例的最常见药物。本研究的目的是估计可预防的药物相关住院病例的百分比、可预防住院病例的最常见药物原因以及可预防的药物相关住院病例的最常见潜在原因。
通过文献数据库以及符合条件的文章和研究作者的参考文献列表获取数据。选取了17项前瞻性观察性研究,这些研究报告了可预防的药物相关住院病例的比例、致病药物和/或住院原因。纳入的研究使用多名评审员和/或明确的标准来评估住院病例的因果关系和可预防性。两名研究人员使用特制的数据提取表从所有纳入的研究中提取数据。
在13篇论文中,可预防的药物相关住院病例的中位数百分比为3.7%(范围为1.4%-15.4%)。在9篇论文中,大多数(51%)可预防的药物相关住院病例涉及抗血小板药物(16%)、利尿剂(16%)、非甾体抗炎药(11%)或抗凝剂(8%)。在5项研究中,与处方问题相关的可预防药物相关住院病例的中位数比例为30.6%(范围为11.1%-41.8%),与依从性问题相关的为33.3%(范围为20.9%-41.7%),与监测问题相关的为22.2%(范围为0%-31.3%)。
四组药物占与可预防的药物相关住院病例相关的药物组的50%以上。将干预措施集中在这些药物组上,可以显著减少基层医疗中可预防的药物相关住院病例数量。